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The effects of 12-O-tetradeeanoyl-phorbol-13-acetate (TPA) on the mRNA levels of two enzymes, thromboxane synthase (TXS) and prostaglandin 
endoperoxide synthase (PES), responsible for the synthesis of thromboxane A, from amchidonic acid, were studied in human erytltroleukcmia 
(HEL) celh by RNA blot analysis. TPA induced beth TXS and PE$ mRNAs in HEL cells in a dose-dependent manner at 36 h. The half-maximal 
and maximal effects for the induction of both mRNAs were at approximately 3x10 -~ M and at 10 -~ M, respectively. TX$ and PES mRNA leveh 
• increased in a time.dependent fashion by TPA, and reached to 7- and 3.5-fold of the control0 r~pectively alter 48 h of TPA treatment. These results 
suggest that expression of TXS and PES genes in HEL cells were simultaneously timulated by TPA. 
Thromboxane synthase; Pro~taglandin endoperoxide synthase; 12-O-Tetradec.anoyl-phorbol.13-aeetate 
1. INTRODUCTION 
Thromboxane (TX) A~. is a potent stimulator of 
platelet aggregation and constrictor of smooth muscles 
[l,2], and is regarded as a mediator in myocardial in- 
farction, atheroselerosis, and bronchial asthma [3]. Syn- 
thesis of TXA.~ from arachidonic acid is catalyzed by 
two enzymes, prostaglandin endoperoxide synthase 
(PES) and TX synthase (TXS) [4,5]. Recently, the clon- 
ing of eDNA coding for PES has been reported [6--10], 
and the regulation of PES gone expression by several 
factors, including TPA, platelet-derived growth factor, 
etc., has been studied extensively [11]. More recently, we 
and Ohashi et al. reported the cloning eDNA encoding 
human platelet [12] and lung TXS [13], respectively. 
Furthermore, TXS mRNA was found to be expressed 
in platelets and human erythroleukemia (I-IEL) cells 
[12]. However, little is known about the regulation of 
gone expression of TXS and the relationship between 
the expression of PES and TXS genes. 
HEL ceils exhibit some erythroid features including 
the presence of hemoglobin, but they also possess the 
markers corresponding to megakaryocyte/platelet sur- 
face glycoproteins, and platelet ~t-granule proteins, 
which are induced by the treatment of TPA [14]. TPA 
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also induces morphological, functional, and biochemi- 
cal properties in HEL cells that are characteristic for 
megakaryoeytie cells [14] and macrophage-like cells 
[15]. Thus, the HEL cell line provides a unique in vitro 
model system for studying the molecular events in- 
volved in TXS gone expression. 
In this report, wc demonstrate that TPA increases the 
levels of TXS mRNA in a dose- and time-dependent 
fashion in HEL cells, which is similar to that of PES 
mRNA by TPA. 
2. MATERIALS AND METHODS 
2.1. Materials 
HEL cells were kindly provided by Dr. S. Narumiya (Kyoto Univer- 
sity). RPM11640 medium was obtained from Gil~o/BRL, fetal bovine 
serum from Flow laboratories, 12.0.tetradeeal:oyl-phorbol.13.aee. 
tate from Sigma, nd [~t- PldCTP (i 10 TBq/mmoi) from Amcrsham. 
Other reagents were described previously [16]. 
2.2. Cell culture 
HEL cells [17] were maintained in suspension i RPMI 1640 me- 
dium supplemented with 10% (v/v) fetal bovine scram, penicillin (100 
U/ml), and ~treptomycin (100 btgtml) at 37°C in a humidified atmos- 
phere o1" 5% COn in air. Cultun,~ were pazmSed 2-3 tim~ a week to 
maintain a log-phase growth. ForTPA treatments, cells were placed 
in fresh medium at 1.2 × 107 celB/150 mm dish and were cultured for 
an additional lfl h. TPA was then add~ to the culture medium from 
a stock solution prepared in ethanol. Control cells re~ived the ~am¢ 
amount of ethanol (0.05%), Cell viability at thecell culture was esti- 
mated by Trypan blue exclusion to be more than 95%. 
2.3. RNA isolation ctnd RNA blot hybridt:ation a alysis 
Total RNA was isolated according to thcaeid gaanidiniara thioeya- 
nate procedure [18]. Adherent HEL cells ~n 15O-mm dishes were lysed 
with 4 M guanidine thio.',./anate, 25 mM sodium citrate (,oH 7.0), 0.~% 
Published by Elsevier Scieuce P,~blishers B.V. 161 
Volume 306, number 2,3 FEBS LETTERS July 1992 
N-lauroylsarcosine, and 0,1 M 2-mereaptoethanol, N n.adherent cells 
were collected by centrifugation a d lysed with the same solution. The 
lysate was passed through an 18.gauge needle three times to shear 
chromosomal DNA, The RNA was extracted in sodium acetate (pH 
4,0) and phenol.-chloroforna and precipitated in isopropanol, Total 
RNA (20 ug) was run on a 1,2% agarose gel according to the proce- 
dure described by Miyakoshi et al, [19] and transferred to a nylon 
membrane, The eDNA probes used for the analyses of the two 
mRNAs were as follows: for PES mRNA, the 1,7 kb EcoRl fragment 
of the PES eDNA clone (AHEPES 13) isolated from a eDNA library 
of human endothelial cells (unpublished data); for TXS mRNA, the 
1,2 kb fragment derived from pHPTX.q6 [12], The probes were labeled 
by the random primer labeling method [20]; specific radioaetivities 
were 1,0-1,5 × 10 ~ cpm//.tg. The mRNA levels were calculated on the 
basis of hybridization signals measured by a Fujix Bio-image analyzer 
BAS 2000 (Fuji Photo Film Co,, Tokyo). The relative intensity meas- 
ured in the hybridization signal was linear within the ranges of 5-30 
/.tg of total RNA, 
3. RESULTS AND DISCUSSION 
A 
With the use of the eDNA clone for human platelet 
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TXS, we examined the effect of TPA on TXS mRNA 
levels in the HEL cell line by RNA blot analysis. At 
first, to test the dose-dependent effect on TXS mRNA 
levels, HEL ceils were incubated with various concen- 
trations of TPA for 36 h. The total RNA was isolated 
and subjected to quantitation of relative levels of TXS 
mRNA. As shown in Fig. IA, TPA increased TXS 
mRNA levels half-maximally at approximately 3 x 10 -9 
M and maximally at 10 -~ M. Above 10 -7 M TXS 
mRNA levels decreased with an increasing concentra- 
tion of TPA. We also treated the dose-dependency to 
TPA in PES mRNA levels by using its eDNA clone, 
because PES supplies the sttbstrate of TXS, prosta- 
glandin H2. A similar sensitivity to TPA was observed 
in the induction of PES mRNA. This induction was 
one-half maximal at about 3 × 10 -9 M and maximal at 
10 -~ M. PES mRNA levels also decreased at concentra- 
tions over 10 -7 M TPA (Fig. 1B). Interestingly, the 
dose-dependent cun, es of the increase in both TXS and 
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Fig. I. Dose.dependent ffects of TPA on TXS and PES mRNA levels. Total RNA was prepared from HEL cells treated with varioas eelxeentrations 
of TPA for 36 h, and RNA blot hybridization analysis was performed as described in Materials and Methods. The mRNA levels ofTXS (A) and 
PES (B) were determined by the Image Analyzer, with the zero time l vel taken as 100°,%. Data are the mean +_. S.D, of quadruplicate d terminations. 
(C) Induction of adherence of HEL cells at 36 h after addition of various concentrations of TPA (magnification x 100), 
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Fig. 2. Time--course of changes inTXS and PES mRNA levels in HEL 
cells after addition of TPA. Experimental details are described in
Materials and Methods. Total RNA analyzed was prepared lYom 
HEi. cells immediately before (0 h) or at the indicated times after 
addition ofTPA (10 -" M). The mRNA levels of'rxs (A) and PE$ (B) 
were determined bythe image analyzer with the zere time l vel ~aken 
as 100%. Data are the mean :1: $.D. of quadruplicate d termina'~-ons. 
Inset, representative RNA blot analysis; TPA (~-) and TPA (-) indi- 
cate total RNA isolated from cells incubated with and without TPA, 
respectively, at indicated times. Ethidium bromide staining of the 28 
S ribosomal RNA corresponding to each lane is shown. 
PES mRNAs by TPA were similar to that of induction 
of adherence in HEL cells. The critical concentration of 
the induction of adherence was also between 10 -9 and 
10 -8 M. At TPA concentrations lower than 10 -9 M, 
HEL cells behaved like the control culture even after 36 
h of incubation. In contrast, above a concentration of 
10 -s M, HEL cells were dramatically changed to adher- 
ent cells (Fig. 1C, [15]). These observations suggest that 
the stimulation of expression of  PES and TXS genes by 
TPA in HEL cells might be associated with the induc- 
tion of morphological change of the cells. 
To analyze the time-course for induction of  TXS and 
PES mRNA levels, HEL cells were incubated in the 
presence of 10 -~ M TPA for various l~riods. Total 
RNA was isolated and analyzed by RNA blot hybridi- 
zaton. TXS mRNA levels gradually increased and led 
to an elevation of about 2-fold of the control after 24 
h of the treatment. After 48-h incubation with TPA, the 
mRNA levels reached 7-fold of that of the control. In 
contrast, there was no apparent change in TXS mRNA 
levels in the absence of TPA (Fig. 2A). The results of 
PES mRNA induction shown in Fig. 2B indicate that 
the content of PES mRNA was also elevated time-de- 
pendently 1.8-fold after 24 h of TPA incubation. This 
observation is consistent with the results reported by 
Funk et al. [10]. Furthermore, PES mRNA levels in- 
creased 3.5-fold above control values 48 h following the 
TPA addition. These results suggest that the expression 
of TXS gene is simultaneously regulated with the PES 
gene by TPA in HEL cells. Lag periods of about 10 h 
occured before an increase in both mRNA levels by 
TPA were seen. The relatively late induction suggests 
that the effect of TPA might be indirect and require an 
ongoing synthesis. Although c-jun and c-fox mRNAs 
are induced rapidly and transiently by TPA in most cells 
[21], c-/un mRNA is greatly stabilized [22], and c-los 
mRNA remains elevated throughout the TPA-indueed 
differentiation in the megakaryoeytoid leukemia line, 
K562 [23]. By analogy, the late induction of  TXS and 
PES mgNAs by TPA might be due to the prolonged 
induction of c-jun and c-fox mRNAs in HEL cells. 
This report provides the first evidence indicating that 
thromboxane synthase is regulated at the mRNA level 
by TPA. Furthermore, TPA induced both TXS and PES 
mRNAs in HEL cells in a similar dose- and time-de- 
pendent manner, suggesting that the expression of both 
genes is simultaneously regulated by TPA. At present, 
the localization of TPA-responsive lement (TRE) in 
the human TXS gene is not yet known, and it is also not 
known whether or not AP-I and Fos proteins are in- 
volved in the induction of TXS mRNA in TPA-treated 
HEL cells. On the other hand, PES gene, the expression 
of which is simultaneously stimulated with that of the 
TXS gene by TPA, has four putative TREs [24]. To 
elucidate the molecular mechanisms of TPA-mediated 
induction of TXS mRNA, the analysis of the 5' regada- 
tory sequence of the human TXS gene is now in pro- 
gress. 
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